Acro Biomedical Co. Ltd. (ACBM)
0.026
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Acro Biomedical Total Assets (Quarterly) : 0.0039M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0039M |
| December 31, 2025 | 0.0141M |
| September 30, 2025 | 0.0043M |
| June 30, 2025 | 0.0533M |
| March 31, 2025 | 0.0252M |
| December 31, 2024 | 0.032M |
| September 30, 2024 | 0.0387M |
| June 30, 2024 | 0.0453M |
| March 31, 2024 | 0.0508M |
| December 31, 2023 | 0.0585M |
| September 30, 2023 | 0.019M |
| June 30, 2023 | 0.5391M |
| March 31, 2023 | 0.6569M |
| December 31, 2022 | 0.6875M |
| September 30, 2022 | 0.6436M |
| June 30, 2022 | 0.6693M |
| March 31, 2022 | 0.7286M |
| December 31, 2021 | 0.7611M |
| September 30, 2021 | 0.6298M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.7004M |
| March 31, 2021 | 0.9389M |
| December 31, 2020 | 0.9981M |
| September 30, 2020 | 0.9891M |
| June 30, 2020 | 0.9983M |
| March 31, 2020 | 1.019M |
| December 31, 2019 | 0.9321M |
| September 30, 2019 | 1.070M |
| June 30, 2019 | 1.081M |
| March 31, 2019 | 1.140M |
| September 30, 2018 | 1.483M |
| June 30, 2018 | 1.010M |
| March 31, 2018 | 0.8679M |
| December 31, 2017 | 0.7645M |
| September 30, 2017 | 0.5483M |
| June 30, 2017 | 0.0025M |
| March 31, 2017 | 0.002M |
| December 31, 2016 | 0.0024M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Stella Diagnostics, Inc. | 0.1724M |
| Wellgistics Health, Inc. | 30.13M |
| Interpace Biosciences, Inc. | 33.41M |
| Medical Marijuana, Inc. | 66.31M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.4311M |
| Shareholders Equity (Quarterly) | -0.4272M |
| Debt to Equity Ratio | -0.878 |
| Current Ratio | 0.009 |
| Net Debt Paydown Yield | -2.85% |